We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NOVEN: GENERIC FENTANYL PETITIONS 'SUSPICIOUS'
NOVEN: GENERIC FENTANYL PETITIONS 'SUSPICIOUS'
January 11, 2005
Noven Pharmaceuticals claimed in a recent filing with the FDA that its efforts to bring a generic version of Johnson & Johnson's (J&J) Duragesic transdermal pain patch to market are being deliberately blocked by a “suspicious” string of citizen petitions.